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Signalling systems activated under stress are highly conserved,
suggesting adaptive effects of their function. Pathologies
arising from continued activation of such systems may
represent a mismatch between evolutionary programming
and current environments. Here, we use Atlantic salmon
(Salmo salar) in aquaculture as a model to explore this
stance of evolutionary-based medicine, for which empirical
evidence has been lacking. Growth-stunted (GS) farmed fish
were characterized by elevated brain serotonergic activation,
increased cortisol production and behavioural inhibition. We
make the novel observation that the serotonergic system in
GS fish is unresponsive to additional stressors, yet a cortisol
response is maintained. The inability of the serotonergic
system to respond to additional stress, while a cortisol
response is present, probably leads to both imbalance in
energy metabolism and attenuated neural plasticity. Hence, we
propose that serotonin-mediated behavioural inhibition may
have evolved in vertebrates to minimize stress exposure in
vulnerable individuals.
2016 The Authors. Published by the Royal Society under the terms of the Creative Commons
Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted
use, provided the original author and source are credited.
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1. Background
The neurobiology of farmed fish is subject to expanding interest due to increasing concern for the welfare
of production animals [1], and fishes are also progressively replacing mammalian models in biomedical
research [2]. Neural signalling systems activated under stress are highly conserved [3–6], suggesting
adaptive effects of their function. It is therefore a conundrum for evolutionary-based medicine that
pathologies often arise from continued activation of the same systems [7]. One possibility is that
pathologies may have evolved from behavioural responses that were adaptive in more primordial
environments [8–11]. It is assumed that a mismatch between the historic and current environment leads
to normally adaptive responses overriding self-correcting tendencies of emotional mechanisms, and this
leads to pathologies [12]. Empirical investigation into this stance of evolutionary-based medicine is,
however, scarce.
Here, we exploit a model in which such mismatch is prone to occur, namely, Atlantic salmon
(Salmo salar) undergoing rapid domestication [13]. Under aquaculture conditions, it is common to
find a proportion of farmed salmon, which are easily catchable at the surface and exhibit a small
size, anorexia and a behaviourally inhibited profile. Such moribund fish, known as ‘drop outs’ or
‘loser fish’, are well known to farmers but very little is known about the aetiology leading up
to this phenomenon [14,15]. We investigated serotonin (5-hydroxytryptamine, 5-HT) activity in the
brain stem, which contains important monoaminergic nuclei innervating large parts of the brain
[4], and plasma cortisol levels of surface-dwelling growth-stunted (GS) fish as well as healthy
individuals occurring in a commercial aquaculture salmon farm. In the vertebrate brain, 5-HT-
mediated signalling has a crucial role in energy regulation, neural plasticity, behavioural and emotional
control, as well as neuroendocrine responses to stress [16,17]. Sustained serotonergic activation is
associated with chronic stress and stress-induced pathologies, such as depression-like states, in
several animal species [4,16,18–20]. We here report the novel observation that the serotonergic system
in GS fish is not responsive to additional acute stress, while a significant corticosteroid response
is maintained.
2. Material and methods
2.1. Experimental animals and facilities
GS and healthy fish (commercial strain, Aquagen AS) were selected during two sampling trials at a
commercial salmon farm in the Langenuen Straight, Western Norway (60°N). Fish were sampled from
two sea cages (25 × 25 × 30 m depth; approx. 18 750 m3) containing spring smolts. The fish were reared
according to production standards, under a natural light regime and were fed formulated food given
over two equally sized meals from 09.00 to 12.00 and 13.00 to 16.00. We sampled fish two (sampling 1; S1)
and five (sampling 2; S2) months after seawater transfer to control for repeatability and production
phase differences. In this study, we have categorized these two groups as: (i) healthy, normal schooling
individuals with healthy behaviour and feeding responses, displaying high reactivity to environmental
stimuli; and (ii) GS fish, which tended to position themselves towards the edge of the sea cage, close to
the surface and without much reaction to environmental stimuli, including food pellets. Representative
phenotypes are shown in figure 1, and number of individuals collected and their average length and
weight are presented in table 1.
2.2. Acute stress treatment
All fish were captured by quickly netting them out of the cage with a dip net from 2 m depth close
to the net wall. Healthy fish were lured towards the net wall by throwing out feed-pellets and were
caught while feeding. Meanwhile, GS fish remained close to the net wall the whole time and were simply
netted out of the cage. Fish from both groups were either sampled directly after capture or subjected to
a 30 min acute stress test before sampling (see table 1 for n/group). Acute stress consisted of individual
confinement in a circular 12 l plastic bucket containing seawater from a depth of 1 m (at approx. 12°C)
for a period of 30 min after Pottinger & Carrick [21]. Oxygen levels were constantly monitored with an
oxygen probe (Storvik HQ40, Storvik Aqua AS, Sunndalsøra, Norway) and kept above 6 mg l−1 to ensure
that fish were not exposed to hypoxia [22].
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Figure 1. Representative pictures of healthy (a) and GS (b) fish from and aquaculture farm in the Langenuen Straight, Western Norway.
(Photos: Ole Folkedal.)
Table 1. Average length andweight (±s.d.) and number (n) of healthy and GS Atlantic salmon collected during first (S1) and second (S2)
samplings at basal and acute stress conditions.
unstressed stressed
healthy GS healthy GS
S1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
length (cm) 24.7± 0.6 18.9± 0.6 25.1± 0.7 17.8± 0.8
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
weight (g) 176± 13.1 50.3± 7.1 179± 16 42.4± 7.4
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
n 15 14 14 12
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
S2
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
length (cm) 38.2± 1.2 25.4± 0.8 38.2± 1.1 26.1± 0.9
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
weight (g) 721± 81.4 145± 16.8 716± 54.9 162± 18.3
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
n 10 10 10 10
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2.3. Sampling protocol
Fish were euthanized with a strong overdose of 1 g l−1 MS-222 (Finquel®, Argent Chemical Laboratories,
Redmond, WA, USA), which rendered them completely motionless (no opercular movement) within 10 s
of immersion. Fish were rapidly weighed, fork length measured and a blood sample was taken from
the caudal vessels with 23 G, 1 ml syringes containing the anticoagulant ethylene diamine tetra acetic
acid (EDTA). Following centrifugation for 5 min at 9.289 rcf and 4°C, plasma samples were frozen and
stored at −80°C for later analysis. Fish were decapitated and the brain stem was quickly excised within
2 min. Brain stems were wrapped in individually marked aluminium foil packets, snap-frozen in liquid
nitrogen and stored at −80°C for later analysis of 5-HT neurochemistry.
2.4. Brain stem serotonergic neurochemistry
Frozen brain stems were homogenized in 4% (w/v) ice cold perchloric acid (PCA) containing 0.2%
EDTA and 3,4-dihydroxybenzyl amine hydrobromide (DHBA, 40 ng ml−1) as an internal standard using
a Potter–Elvehjem homogenizer. After spinning samples for 10 min at 15.493 rcf and 4°C, the supernatant
was analysed by means of high-performance liquid chromatography (HPLC). The mobile phase was
made up of 12 µM EDTA, 86 mM sodium phosphate and 1.4 mM sodium octyl sulfate in deionized
water (resistance 18.2 MW), containing 7% acetonitrile set to pH 3.1 using phosphoric acid. The system
contains a solvent delivery system (Shimadzu, LC-10AD), an auto-injector (Famos, Spark), a reverse-
phase column (4.6 mm 100 mm, Hichrom, C18, 3.5 mm) and an ESA Coulochem II detector (ESA, Bedford,
MA, USA) with two electrodes at −40 mV and +320 mV. A conditioning electrode with a potential
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of +40 mV was used to oxidize possible contaminants before analysis. Brain stem concentrations of
5-HT and the 5-HT catabolite 5-hydroxyindoleacetic acid (5-HIAA) were quantified by comparison
with standards and corrected for recovery of the internal standard using HPLC software (CSW, Data
Apex Ltd, the Czech Republic).
2.5. Cortisol radioimmunoassay
Plasma samples were diluted 2.2 times in assay buffer and cortisol assayed by radioimmunoassay (RIA)
following the procedure described by Gorissen et al. [23]. Intra- and interassay variations were 12.5% and
3.5%, respectively, and cross-reactivity of the cortisol antibody (antibody [xm210]; Abcam, Cambridge,
MA, USA) was as follows: cortisol 100%, 11-deoxycortisol 0.9%, prednisolone 5.6%, corticosterone 0.6%,
11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, testosterone, oestradiol and oestriol all
less than 0.01%.
2.6. Statistical analyses
All datasets were tested by Levene’s test for variance homogeneity, and values were either log- (cortisol,
5-HT and 5-HIAA) or arcsine-transformed (5-HIAA/5-HT ratios) when necessary. A two-way ANOVA
was used to compare concentrations of 5-HT, 5-HIAA, cortisol and the 5-HIAA/5-HT ratios for each
sampling, with fish type (GS versus healthy control) and treatment (basal versus acute stress) as
independent variables, followed by a Tukey–Kramer honestly significant difference (HSD) post hoc test
when a significant interaction effect was indicated.
3. Results
3.1. Brain stem 5-hydroxytryptamine neurochemistry
We investigated 5-HT neurochemistry at basal conditions and after acute stress in groups of healthy
and GS salmon at two different time points (two and five months following transfer to seawater
rearing, i.e. S1 and S2, respectively). At both time points, GS fish sustained significantly higher
levels of the principal 5-HT catabolite 5-HIAA compared with healthy controls (p< 0.001 in both
samplings). Interestingly, whereas 5-HIAA levels were significantly increased by confinement stress in
controls (post hoc pS1 = 0.001, pS2 = 0.002), 5-HIAA levels did not differ between basal and confinement
stress (pS1 = 0.96, pS2 = 0.87) in the GS fish (figure 2b,e), indicating a blunted serotonergic response
to stress in these individuals. Meanwhile, there was a significant effect of phenotype on the 5-HIAA/
5-HT ratio (pS1 = 0.008 and pS2< 0.001) in both samplings, where healthy fish displayed lower ratios
than GS fish (figure 2c,f ). For 5-HT concentrations, there was a discrepancy between the two samplings,
whereas there was a fish-type effect during S1 in which healthy fish had significantly lower 5-HT
levels compared with GS fish (p< 0.01), this difference was not statistically significant in S2 (p= 0.13).
Nevertheless, we found that on both samplings there was neither a stress nor an interaction effect on
5-HT (figure 2a,d).
3.2. Plasma cortisol levels
At both time points of sampling, plasma cortisol was affected by both type (pS1< 0.001 and pS2 = 0.02)
and stress (p≤ 0.001 in both samplings), with no interaction effect between the two variables (p= 0.1 in
both). Plasma cortisol levels were significantly lower in healthy fish compared with GS fish. However,
both groups responded with increased plasma cortisol levels to confinement stress (figure 3).
4. Discussion
The occurrence of GS fish is a common and costly occurrence in salmon aquaculture, affecting up to a
quarter of the stock, but little has been done to elucidate the aetiology of this phenotype. We here present,
for the first time, physiological data for GS fish, showing that elevated serotonergic activity is a main
characteristic of the GS phenotype. That is, compared with healthy fish, GS salmon are characterized by
increased basal brain serotonergic activity and cortisol production measured over two samplings several
months apart, which suggest chronic activation of the serotonergic and hypothalamic-pituitary interrenal
(HPI) axis systems [6,24,25]. Our findings support the view that research focusing on genetic markers
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Figure 2. Effect of fish type (i.e. healthy versus GS) and stress (basal versus acute stress) on serotonin (5-HT) neurochemistry in the brain
stem of Atlantic salmon at S1 (a–c) and S2 (d–f ). Two-way ANOVA statistics are given in figure for each panel. Small letters indicate
a fish-type effect or Tukey–Kramer HSD post hoc differences following a significant interaction effect. Data represent mean± s.e.m.
for stress coping abilities in farmed fish is necessary to improve welfare and selection for breeding.
Intriguingly, a growing body of evidence indicates that several depression-like syndromes are associated
with increased serotonergic signalling (for a review, see [17]). In this context, it is interesting to note that
the behavioural and serotonergic profile exhibited by GS fish is reminiscent of a depressed state, similar
to those described in mammals [17,26–28]. However, further research is needed in order to corroborate
this possibility.
Both 5-HIAA levels and the 5-HIAA/5-HT ratios as well as plasma cortisol levels observed during
both samplings in GS fish at basal conditions indicate chronic serotonergic and HPI axis activation
[6,24,25]. Notably, there were two discrepancies between both samplings. First, measured plasma cortisol
and 5-HT levels were overall higher in all groups during S1, compared with S2. Both cortisol and 5-HT
concentrations are known to vary with the life stage of the fish and most notably cortisol and 5-HT
increase during smoltification (the metamorphosis that prepares salmon for the saltwater environment).
That is, an increase during smoltification in brain 5-HT and plasma cortisol concentrations of up to
50% [29] and up to 100% [30], respectively, has been reported. In our experiment, fish were sampled
shortly after smoltification (S1) and five months later (S2). In line with these reports, both 5-HT and
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Figure 3. Effect of fish type (i.e. healthy versus GS) and stress (basal versus acute stress) on plasma cortisol concentrations in Atlantic
salmon, at S1 (a) andS2 (b). Two-wayANOVAstatistics aregiven infigure for eachpanel. Small andbig letters indicate a typeand treatment
effect, respectively. Data represent mean± s.e.m.
plasma cortisol levels were higher at the sampling point closest to smoltification. Second, while basal
serotonergic activity was found to be consistently higher, at both sampling points, in GS fish compared
with healthy individuals, 5-HT concentrations were similarly higher in GS fish compared with healthy
fish in S1 only. However, 5-HT concentrations do not directly reflect serotonergic signalling. Firstly, 5-HT
is rapidly replaced by newly synthetized 5-HT intracellularly following its release at the synapse [31]
and secondly, extracellular 5-HT concentrations reflect both 5-HT release and clearance from the synapse
[17]. Instead, 5-HIAA levels and the 5-HIAA/5-HT ratio are used as a proxy for serotonergic activity
[6,17,31,32], as the formation of the 5-HT catabolite 5-HIAA is almost exclusively a result of monoamine
oxidase metabolizing 5-HT after release into the synapse and reuptake into the presynaptic neuron or
surrounding cells. Our most important finding is that the serotonergic system of GS fish is unresponsive
to acute novel stress. This phenomenon has, to the best of our knowledge, never been shown before,
but is a classic example of allostatic overload in a physiological system (i.e. the inability of regulatory
mechanisms to react to further challenge). The inability of the serotonergic system to respond to novel
acute stressors, while a cortisol response is maintained, probably leads to both an imbalance in energy
metabolism [17] and attenuated neural plasticity [5,33]. Therefore, the passive-behavioural phenotype
characteristic of GS fish may be mediated by sustained serotonergic activation in order to minimize
further stress exposure.
Although we have established that GS fish suffer from an elevated activation of the serotonergic
system, the underlying causes of the increased serotonergic activity remains to be determined. There
are multiple potential contributors to increased serotonergic activity in farmed salmon. For example,
subordinate social rank within aquaculture populations is associated with chronically increased
serotonergic activity [34]. Furthermore, the strains of Atlantic salmon used in aquaculture have gone
through a rapid and intense domestication, and the aquaculture environment challenges individuals
with a series of stressors that do not occur in nature [13]. For example, vaccinating fish shortly after
smoltification (a common practice in aquaculture [35,36]) challenges homeostatic balance, induces
autoimmunity [37] and decreases feed intake for several weeks [36]. Interestingly, both vaccination [38]
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and smoltification [29] alter serotonergic signalling and could lead to prolonged serotonergic activation.
Thus, an environmental mismatch between natural (e.g. smoltification) and ‘artificial’ stressors (e.g.
grading, vaccination) might leave some individuals more vulnerable to disease and behavioural
syndromes [13]. Further investigations are, however, needed to pinpoint the proximate causes of the GS
phenotype, e.g. the possible interaction between genetic effects, immune status and social hierarchies.
Future studies should focus on the environmental factors and genetic, behavioural and physiological
characteristics underpinning GS fish, especially considering that individual differences in vulnerability
are still unresolved [17,39]. We believe that these findings should encourage further exploration of
both the evolutionary background and causative molecular mechanisms for 5-HT-induced behavioural
inhibition. Such knowledge may be pivotal in advancing the development of new clinical approaches to
stress-induced pathologies and may ultimately facilitate a shift in focus to the medical ideal of prevention
rather than cure.
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